Dec 7, 2023 · 40m · how-i-built-this

Full body preventive health care with Andrew Lacy of Prenuvo

Guy Raz · 18m spoken Andrew Lacy · 17m spoken Thomas Silver · 30s spoken
0:00 / 0:00

gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions

Guy Raz interviews Prenuvo co-founder Andrew Lacy to discuss how preventative whole-body MRI technology can transform healthcare from a reactive symptom-based system into an accessible, proactive model. Lacy details Prenuvo's proprietary imaging innovations, business scaling strategy, and clinic design, while directly addressing medical establishment skepticism regarding elective screening.

How this conversation actually went

Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Guy holds 51.4% of the talking time here. How this is scored →

Guy as informed peer 4.0 Guest teaching 4.2 Guest disagreement 0.8 Guy pushing back 1.2
05100:0015:0030:001:26–4:56 · Guy as informed peer 3/10 Andrew Lacy's Journey and the Discovery of Whole-Body MRI Raz opens the interview asking about Lacy's background and how he discovered Dr. Attariwala's clinic in Vancouver. Lacy explains his motivation and the transformative personal impact of getting an asymptomatic screening scan. The tone is entirely conversational and collaborative.4:57–7:42 · Guy as informed peer 5/10 Partnering with Dr. Attariwala to Redefine MRI Utility Raz demonstrates domain familiarity by drawing an analogy to continuous glucose monitors expanding from diabetic patients to healthy individuals. Lacy builds on this concept, explaining how visual feedback from scans motivates preventive lifestyle changes.7:42–10:50 · Guy as informed peer 4/10 Launching Prenuvo and Navigating Early Investor Skepticism Raz questions why venture capital was hesitant given the apparent unit economics. Lacy details the legacy stigma left by 1990s mall CT screening clinics and physician skepticism among VC advisory boards.10:50–14:28 · Guy as informed peer 0/10 Mid-Show Break: Sponsor Messages and Listener Spotlight Mid-show commercial break featuring sponsor messages from Hero Bread and Miro alongside a listener spotlight.14:35–17:40 · Guy as informed peer 5/10 Technical Innovation: Fast MRI and Early Stage Tumor Detection Raz frames the science of early cancer detection, asking how Prenuvo reduced scan duration from multiple hours to one hour. Lacy explains custom 1.5 Tesla magnet hardware configurations and tissue hardness filtration algorithms.17:40–21:26 · Guy as informed peer 6/10 Addressing Medical Pushback and the Screening Evidence Debate Raz directly challenges Lacy with the medical establishment's widespread opposition and concern over false positives. Lacy pushes back on Raz's premise, clarifying that clinical guidelines cite a lack of population evidence rather than a lack of individual efficacy.21:26–26:12 · Guy as informed peer 6/10 Population Health Statistics Versus Individual Peace of Mind Raz quotes prominent radiologist Dr. Rebecca Smith-Bindman regarding the risks of detecting benign incidentalomas leading to over-treatment. Lacy counters by differentiating statistical population-level public health models from individual survival decisions.26:14–29:26 · Guy as informed peer 3/10 Mid-Episode Station Bumper Raz shares his personal experience using Prenuvo to detect cervical spine degeneration, prompting Lacy to explain early spinal diagnostic screening.29:27–31:40 · Guy as informed peer 5/10 Business Operations, Pricing Strategy, and Custom Hardware Raz asks practical operational questions about how Prenuvo manages radiologist costs and whether proprietary hardware or offshore readers are used. Lacy outlines their whole-body specialist staffing model.31:40–35:16 · Guy as informed peer 4/10 Patient Demographics, Future Affordability, and Second Opinions Raz raises socioeconomic critiques about scan affordability and questions whether patients require secondary opinions. Lacy clarifies demographic realities, noting most customers are cancer survivors or patients with unexplained symptoms rather than biohackers.35:16–38:10 · Guy as informed peer 3/10 Organic Growth, Celebrity Impact, and De-Stigmatizing Healthcare Visits Raz inquires about celebrity endorsements and clinic hospitality. Lacy explains how hospitality and entertainment options reduce claustrophobia and medical anxiety.38:11–40:16 · Guy as informed peer 4/10 Scaling the Vision: A Preventative Standard of Care Raz asks Lacy about his long-term expansion goals and national scalability. Lacy lays out macroeconomic calculations comparing biennial population scanning costs to annual expenditures on late-stage cancer therapeutics.1:26–4:56 · Guest teaching 4/10 Andrew Lacy's Journey and the Discovery of Whole-Body MRI Raz opens the interview asking about Lacy's background and how he discovered Dr. Attariwala's clinic in Vancouver. Lacy explains his motivation and the transformative personal impact of getting an asymptomatic screening scan. The tone is entirely conversational and collaborative.4:57–7:42 · Guest teaching 3/10 Partnering with Dr. Attariwala to Redefine MRI Utility Raz demonstrates domain familiarity by drawing an analogy to continuous glucose monitors expanding from diabetic patients to healthy individuals. Lacy builds on this concept, explaining how visual feedback from scans motivates preventive lifestyle changes.7:42–10:50 · Guest teaching 4/10 Launching Prenuvo and Navigating Early Investor Skepticism Raz questions why venture capital was hesitant given the apparent unit economics. Lacy details the legacy stigma left by 1990s mall CT screening clinics and physician skepticism among VC advisory boards.10:50–14:28 · Guest teaching 0/10 Mid-Show Break: Sponsor Messages and Listener Spotlight Mid-show commercial break featuring sponsor messages from Hero Bread and Miro alongside a listener spotlight.14:35–17:40 · Guest teaching 5/10 Technical Innovation: Fast MRI and Early Stage Tumor Detection Raz frames the science of early cancer detection, asking how Prenuvo reduced scan duration from multiple hours to one hour. Lacy explains custom 1.5 Tesla magnet hardware configurations and tissue hardness filtration algorithms.17:40–21:26 · Guest teaching 6/10 Addressing Medical Pushback and the Screening Evidence Debate Raz directly challenges Lacy with the medical establishment's widespread opposition and concern over false positives. Lacy pushes back on Raz's premise, clarifying that clinical guidelines cite a lack of population evidence rather than a lack of individual efficacy.21:26–26:12 · Guest teaching 6/10 Population Health Statistics Versus Individual Peace of Mind Raz quotes prominent radiologist Dr. Rebecca Smith-Bindman regarding the risks of detecting benign incidentalomas leading to over-treatment. Lacy counters by differentiating statistical population-level public health models from individual survival decisions.26:14–29:26 · Guest teaching 4/10 Mid-Episode Station Bumper Raz shares his personal experience using Prenuvo to detect cervical spine degeneration, prompting Lacy to explain early spinal diagnostic screening.29:27–31:40 · Guest teaching 4/10 Business Operations, Pricing Strategy, and Custom Hardware Raz asks practical operational questions about how Prenuvo manages radiologist costs and whether proprietary hardware or offshore readers are used. Lacy outlines their whole-body specialist staffing model.31:40–35:16 · Guest teaching 5/10 Patient Demographics, Future Affordability, and Second Opinions Raz raises socioeconomic critiques about scan affordability and questions whether patients require secondary opinions. Lacy clarifies demographic realities, noting most customers are cancer survivors or patients with unexplained symptoms rather than biohackers.35:16–38:10 · Guest teaching 4/10 Organic Growth, Celebrity Impact, and De-Stigmatizing Healthcare Visits Raz inquires about celebrity endorsements and clinic hospitality. Lacy explains how hospitality and entertainment options reduce claustrophobia and medical anxiety.38:11–40:16 · Guest teaching 5/10 Scaling the Vision: A Preventative Standard of Care Raz asks Lacy about his long-term expansion goals and national scalability. Lacy lays out macroeconomic calculations comparing biennial population scanning costs to annual expenditures on late-stage cancer therapeutics.1:26–4:56 · Guest disagreement 0/10 Andrew Lacy's Journey and the Discovery of Whole-Body MRI Raz opens the interview asking about Lacy's background and how he discovered Dr. Attariwala's clinic in Vancouver. Lacy explains his motivation and the transformative personal impact of getting an asymptomatic screening scan. The tone is entirely conversational and collaborative.4:57–7:42 · Guest disagreement 0/10 Partnering with Dr. Attariwala to Redefine MRI Utility Raz demonstrates domain familiarity by drawing an analogy to continuous glucose monitors expanding from diabetic patients to healthy individuals. Lacy builds on this concept, explaining how visual feedback from scans motivates preventive lifestyle changes.7:42–10:50 · Guest disagreement 1/10 Launching Prenuvo and Navigating Early Investor Skepticism Raz questions why venture capital was hesitant given the apparent unit economics. Lacy details the legacy stigma left by 1990s mall CT screening clinics and physician skepticism among VC advisory boards.10:50–14:28 · Guest disagreement 0/10 Mid-Show Break: Sponsor Messages and Listener Spotlight Mid-show commercial break featuring sponsor messages from Hero Bread and Miro alongside a listener spotlight.14:35–17:40 · Guest disagreement 0/10 Technical Innovation: Fast MRI and Early Stage Tumor Detection Raz frames the science of early cancer detection, asking how Prenuvo reduced scan duration from multiple hours to one hour. Lacy explains custom 1.5 Tesla magnet hardware configurations and tissue hardness filtration algorithms.17:40–21:26 · Guest disagreement 4/10 Addressing Medical Pushback and the Screening Evidence Debate Raz directly challenges Lacy with the medical establishment's widespread opposition and concern over false positives. Lacy pushes back on Raz's premise, clarifying that clinical guidelines cite a lack of population evidence rather than a lack of individual efficacy.21:26–26:12 · Guest disagreement 3/10 Population Health Statistics Versus Individual Peace of Mind Raz quotes prominent radiologist Dr. Rebecca Smith-Bindman regarding the risks of detecting benign incidentalomas leading to over-treatment. Lacy counters by differentiating statistical population-level public health models from individual survival decisions.26:14–29:26 · Guest disagreement 0/10 Mid-Episode Station Bumper Raz shares his personal experience using Prenuvo to detect cervical spine degeneration, prompting Lacy to explain early spinal diagnostic screening.29:27–31:40 · Guest disagreement 0/10 Business Operations, Pricing Strategy, and Custom Hardware Raz asks practical operational questions about how Prenuvo manages radiologist costs and whether proprietary hardware or offshore readers are used. Lacy outlines their whole-body specialist staffing model.31:40–35:16 · Guest disagreement 1/10 Patient Demographics, Future Affordability, and Second Opinions Raz raises socioeconomic critiques about scan affordability and questions whether patients require secondary opinions. Lacy clarifies demographic realities, noting most customers are cancer survivors or patients with unexplained symptoms rather than biohackers.35:16–38:10 · Guest disagreement 0/10 Organic Growth, Celebrity Impact, and De-Stigmatizing Healthcare Visits Raz inquires about celebrity endorsements and clinic hospitality. Lacy explains how hospitality and entertainment options reduce claustrophobia and medical anxiety.38:11–40:16 · Guest disagreement 0/10 Scaling the Vision: A Preventative Standard of Care Raz asks Lacy about his long-term expansion goals and national scalability. Lacy lays out macroeconomic calculations comparing biennial population scanning costs to annual expenditures on late-stage cancer therapeutics.1:26–4:56 · Guy pushing back 0/10 Andrew Lacy's Journey and the Discovery of Whole-Body MRI Raz opens the interview asking about Lacy's background and how he discovered Dr. Attariwala's clinic in Vancouver. Lacy explains his motivation and the transformative personal impact of getting an asymptomatic screening scan. The tone is entirely conversational and collaborative.4:57–7:42 · Guy pushing back 0/10 Partnering with Dr. Attariwala to Redefine MRI Utility Raz demonstrates domain familiarity by drawing an analogy to continuous glucose monitors expanding from diabetic patients to healthy individuals. Lacy builds on this concept, explaining how visual feedback from scans motivates preventive lifestyle changes.7:42–10:50 · Guy pushing back 1/10 Launching Prenuvo and Navigating Early Investor Skepticism Raz questions why venture capital was hesitant given the apparent unit economics. Lacy details the legacy stigma left by 1990s mall CT screening clinics and physician skepticism among VC advisory boards.10:50–14:28 · Guy pushing back 0/10 Mid-Show Break: Sponsor Messages and Listener Spotlight Mid-show commercial break featuring sponsor messages from Hero Bread and Miro alongside a listener spotlight.14:35–17:40 · Guy pushing back 0/10 Technical Innovation: Fast MRI and Early Stage Tumor Detection Raz frames the science of early cancer detection, asking how Prenuvo reduced scan duration from multiple hours to one hour. Lacy explains custom 1.5 Tesla magnet hardware configurations and tissue hardness filtration algorithms.17:40–21:26 · Guy pushing back 5/10 Addressing Medical Pushback and the Screening Evidence Debate Raz directly challenges Lacy with the medical establishment's widespread opposition and concern over false positives. Lacy pushes back on Raz's premise, clarifying that clinical guidelines cite a lack of population evidence rather than a lack of individual efficacy.21:26–26:12 · Guy pushing back 5/10 Population Health Statistics Versus Individual Peace of Mind Raz quotes prominent radiologist Dr. Rebecca Smith-Bindman regarding the risks of detecting benign incidentalomas leading to over-treatment. Lacy counters by differentiating statistical population-level public health models from individual survival decisions.26:14–29:26 · Guy pushing back 0/10 Mid-Episode Station Bumper Raz shares his personal experience using Prenuvo to detect cervical spine degeneration, prompting Lacy to explain early spinal diagnostic screening.29:27–31:40 · Guy pushing back 2/10 Business Operations, Pricing Strategy, and Custom Hardware Raz asks practical operational questions about how Prenuvo manages radiologist costs and whether proprietary hardware or offshore readers are used. Lacy outlines their whole-body specialist staffing model.31:40–35:16 · Guy pushing back 1/10 Patient Demographics, Future Affordability, and Second Opinions Raz raises socioeconomic critiques about scan affordability and questions whether patients require secondary opinions. Lacy clarifies demographic realities, noting most customers are cancer survivors or patients with unexplained symptoms rather than biohackers.35:16–38:10 · Guy pushing back 0/10 Organic Growth, Celebrity Impact, and De-Stigmatizing Healthcare Visits Raz inquires about celebrity endorsements and clinic hospitality. Lacy explains how hospitality and entertainment options reduce claustrophobia and medical anxiety.38:11–40:16 · Guy pushing back 0/10 Scaling the Vision: A Preventative Standard of Care Raz asks Lacy about his long-term expansion goals and national scalability. Lacy lays out macroeconomic calculations comparing biennial population scanning costs to annual expenditures on late-stage cancer therapeutics.

speaking balance: gold is Guy, purple is the guest (3 minute bins)

0:00 · Guy 75.6% · guest 24.4%0:00 · Guy 75.6% · guest 24.4%3:00 · Guy 24.4% · guest 75.6%3:00 · Guy 24.4% · guest 75.6%6:00 · Guy 44% · guest 56%6:00 · Guy 44% · guest 56%9:00 · Guy 64.8% · guest 35.2%9:00 · Guy 64.8% · guest 35.2%12:00 · Guy 81% · guest 19%12:00 · Guy 81% · guest 19%15:00 · Guy 47.8% · guest 52.2%15:00 · Guy 47.8% · guest 52.2%18:00 · Guy 61.5% · guest 38.5%18:00 · Guy 61.5% · guest 38.5%21:00 · Guy 46.6% · guest 53.4%21:00 · Guy 46.6% · guest 53.4%24:00 · Guy 67.2% · guest 32.8%24:00 · Guy 67.2% · guest 32.8%27:00 · Guy 57.7% · guest 42.3%27:00 · Guy 57.7% · guest 42.3%30:00 · Guy 36.7% · guest 63.3%30:00 · Guy 36.7% · guest 63.3%33:00 · Guy 31.4% · guest 68.6%33:00 · Guy 31.4% · guest 68.6%36:00 · Guy 30.2% · guest 69.8%36:00 · Guy 30.2% · guest 69.8%39:00 · Guy 47.2% · guest 52.8%39:00 · Guy 47.2% · guest 52.8%
Sharpest disagreement ▶ 19:25 Lacy disputes Raz's framing of medical opposition

Lacy directly interrupts and rejects Raz's premise that medical associations completely oppose the scans, stating Raz mischaracterized clinical statements regarding population evidence versus individual utility.

Hardest push from Guy ▶ 24:30 Raz challenges Lacy with UCSF radiology director's critique

Raz quotes UCSF radiology chief Dr. Smith-Bindman to press Lacy on the risk that full-body scans uncover harmless benign tumors that trigger unnecessary, invasive interventions.

Biggest teaching moment ▶ 25:44 Lacy distinguishes population health metrics from individual risk

Lacy reframes the medical debate by explaining that public health guidelines treat citizens as statistics, whereas individual patients cannot accept risk when only given one life.

Guy holds their own ▶ 5:57 Raz draws parallel to consumer continuous glucose monitoring

Raz displays strong industry pattern-recognition by linking Prenuvo's consumer screening model to the transition of CGMs from diabetic medical devices to general wellness tools.

the scores for every segment, with the reasoning behind each
ChapterTopicGuy as informed peerGuest teachingGuest disagreementGuy pushing backWhy
Andrew Lacy's Journey and the Discovery of Whole-Body MRI 3400 Raz opens the interview asking about Lacy's background and how he discovered Dr. Attariwala's clinic in Vancouver. Lacy explains his motivation and the transformative personal impact of getting an asymptomatic screening scan. The tone is entirely conversational and collaborative.
Partnering with Dr. Attariwala to Redefine MRI Utility 5300 Raz demonstrates domain familiarity by drawing an analogy to continuous glucose monitors expanding from diabetic patients to healthy individuals. Lacy builds on this concept, explaining how visual feedback from scans motivates preventive lifestyle changes.
Launching Prenuvo and Navigating Early Investor Skepticism 4411 Raz questions why venture capital was hesitant given the apparent unit economics. Lacy details the legacy stigma left by 1990s mall CT screening clinics and physician skepticism among VC advisory boards.
Mid-Show Break: Sponsor Messages and Listener Spotlight 0000 Mid-show commercial break featuring sponsor messages from Hero Bread and Miro alongside a listener spotlight.
Technical Innovation: Fast MRI and Early Stage Tumor Detection 5500 Raz frames the science of early cancer detection, asking how Prenuvo reduced scan duration from multiple hours to one hour. Lacy explains custom 1.5 Tesla magnet hardware configurations and tissue hardness filtration algorithms.
Addressing Medical Pushback and the Screening Evidence Debate 6645 Raz directly challenges Lacy with the medical establishment's widespread opposition and concern over false positives. Lacy pushes back on Raz's premise, clarifying that clinical guidelines cite a lack of population evidence rather than a lack of individual efficacy.
Population Health Statistics Versus Individual Peace of Mind 6635 Raz quotes prominent radiologist Dr. Rebecca Smith-Bindman regarding the risks of detecting benign incidentalomas leading to over-treatment. Lacy counters by differentiating statistical population-level public health models from individual survival decisions.
Mid-Episode Station Bumper 3400 Raz shares his personal experience using Prenuvo to detect cervical spine degeneration, prompting Lacy to explain early spinal diagnostic screening.
Business Operations, Pricing Strategy, and Custom Hardware 5402 Raz asks practical operational questions about how Prenuvo manages radiologist costs and whether proprietary hardware or offshore readers are used. Lacy outlines their whole-body specialist staffing model.
Patient Demographics, Future Affordability, and Second Opinions 4511 Raz raises socioeconomic critiques about scan affordability and questions whether patients require secondary opinions. Lacy clarifies demographic realities, noting most customers are cancer survivors or patients with unexplained symptoms rather than biohackers.
Organic Growth, Celebrity Impact, and De-Stigmatizing Healthcare Visits 3400 Raz inquires about celebrity endorsements and clinic hospitality. Lacy explains how hospitality and entertainment options reduce claustrophobia and medical anxiety.
Scaling the Vision: A Preventative Standard of Care 4500 Raz asks Lacy about his long-term expansion goals and national scalability. Lacy lays out macroeconomic calculations comparing biennial population scanning costs to annual expenditures on late-stage cancer therapeutics.

Statements from this episode (18)

Opinion
Lacy: Screening Market for MRIs Is 1,000x Larger Than Diagnostic Market
“There was this potential screening use case for MRI machines that was a thousand times bigger than the diagnostic use case.”
Andrew Lacy Dec 7, 2023 ▶ 4:40
Insight
Lacy: Radiology is constrained by legacy single-body-part imaging assumption
“The single biggest assumption underpinning all radiology today is that you only ever look at one part of the body at a time. And this is a throwback from a 150 years ago when we just had x-ray, an x-ray plate that they put behind your body to take a picture of…”
Andrew Lacy Dec 7, 2023 ▶ 8:25
Assertion Contradicted
Lacy: All Solid Tumors Are Harder Than Surrounding Tissue
“All solid tumors are harder than the surrounding tissue.”
Andrew Lacy Dec 7, 2023 ▶ 17:13
Assertion Not checkable as stated
Prenuvo CEO: Vast Majority of Detected Cancers Are Stage One
“And that's why the vast majority of the cancer that we catch is actually stage one or localized to the organ of origin.”
Andrew Lacy Dec 7, 2023 ▶ 17:20
Prediction Not checkable as stated
Lacy: Whole-body MRI screening will inevitably achieve widespread medical adoption
“And I think these statements that were made actually have also been made about pap smear between when it was invented and when it was adopted, mammograms. So this is a very, very natural Point in the journey from a potentially breakthrough screening technology…”
Andrew Lacy Dec 7, 2023 ▶ 20:10
Assertion Not checkable as stated
Lacy: No public critics of Prenuvo have experienced its scan firsthand
“And there's no one that's really spoken out against these technologies that actually has experienced it firsthand. In fact, most of those people bring their family members in and then start referring their patients.”
Andrew Lacy Dec 7, 2023 ▶ 21:17
Insight
Lacy: Individual healthcare decisions fundamentally differ from population statistics
“It's also an argument that makes sense when you start to consider these interventions at a population level, because at a population level, we're all a statistic. But at the individual level, we only have one life. You know, if we lose that one, we don't get a…”
Andrew Lacy Dec 7, 2023 ▶ 25:53
Assertion Not checkable as stated
Lacy: Prenuvo scans detect chronic disease 10 to 20 years before symptoms
“I think one of the really fascinating things that we have discovered as we started to image more and more patients is we can see oftentimes at very early stages of chronic disease, 1020 years before you might ever feel symptoms.”
Andrew Lacy Dec 7, 2023 ▶ 27:40
Insight
Lacy: Longevity is closely linked to preserving mobility
“Longevity is so closely linked to mobility. Once you lose your mobility, you don't live much longer.”
Andrew Lacy Dec 7, 2023 ▶ 28:08
Assertion Not checkable as stated
Lacy: Prenuvo Detects Cancer or Aneurysms in 1 in 20 Patients
“We just had cancer aneurysms in maybe one in 20 to one in 25 people, depending on the location.”
Andrew Lacy Dec 7, 2023 ▶ 29:19
Disclosure
Lacy: Prenuvo Uses One Multi-Organ Radiologist Per Scan
“So we have one radiologist that looks at the entire body. They're trained in identifying what they see in, in every single organ. And then we have subspecialties that can chime in if there's something abnormal and they need help.”
Andrew Lacy Dec 7, 2023 ▶ 30:16
Assertion Not checkable as stated
Lacy: Cancer survivors and at-risk patients are Prenuvo's largest customer group
“The single biggest category are people that might've had cancer and worried that it's Coming back, or they have a strong family history of cancer, aneurysm, or disease, and for them, not being screened is obviously affecting their quality of life.”
Andrew Lacy Dec 7, 2023 ▶ 32:30
Assertion Not checkable as stated
Lacy: Patients with undiagnosed symptoms form Prenuvo's second-largest demographic
“The second biggest category are people that have actual symptoms, but they're indeterminate. They might have headaches or abdominal pain, particularly women that might have abdominal or pelvic pain, and they don't know what's causing it, and the health system …”
Andrew Lacy Dec 7, 2023 ▶ 32:48
Disclosure
Lacy: Prenuvo aims to offer sub-$500 half-hour full-body scans
“Our goal as a company is one day that these are sub 500 dollar scan. It takes probably about half an hour or less, and they're available most everywhere.”
Andrew Lacy Dec 7, 2023 ▶ 33:22
Assertion Contradicted
Lacy: 10 to 15 percent of patients abort standard MRI procedures
“The average MRI procedure, about 10 to 15% of people can't get through it without pulling the escape hatch.”
Andrew Lacy Dec 7, 2023 ▶ 37:51
Assertion Not checkable as stated
Lacy: Only one percent of Prenuvo patients fail to complete scans
“And at Prenuvo we have about one percent of people that can't get through a scan.”
Andrew Lacy Dec 7, 2023 ▶ 38:06
Assertion Not checkable as stated
Lacy: Scanning every American biennially for cancer would cost ~$60B
“In fact, to just screen for cancer in the U.S. Using the techniques that we use, probably to scan every person in the U.S. Every two years would cost something like sixty billion dollars.”
Andrew Lacy Dec 7, 2023 ▶ 39:13
Assertion Contradicted
Lacy: US spends $130B annually on late-stage cancer drugs
“We spend a hundred and thirty billion dollars on late stage cancer drugs every year, let alone the obviously huge impact of people Passing away from this horrible disease.”
Andrew Lacy Dec 7, 2023 ▶ 39:25
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 800 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.